search
Back to results

Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV (WISH)

Primary Purpose

HIV Infections, Smoking, Smoking Cessation

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Wellness Intervention for Smokers with HIV
Sponsored by
Seattle Institute for Biomedical and Clinical Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for HIV Infections focused on measuring HIV, Smoking, Smoking Cessation, Behavioral Intervention, Remote Intervention, Motivational Interviewing, Veterans

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • In care in the VA
  • HIV+ serostatus
  • Currently smoking 5+ cigarettes daily
  • Access to cell phone with text messaging capabilities
  • English speaking

Exclusion Criteria:

  • Psychosis, dementia or significant cognitive impairment documented in the EHR
  • Documented or observed hearing or comprehension difficulties that would preclude participation in study telephone calls
  • Currently receiving cessation counseling or using an FDA approved treatment to quit smoking
  • Institutionalized/imprisoned
  • Pregnant

Sites / Locations

  • VA Puget Sound Health Care System Seattle DivisionRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control - Standard Care

Intervention - Wellness Intervention for Smokers with HIV

Arm Description

The control intervention is referral to standard evidence-based cessation services available nationally to Veterans, including the National VA Quitline and SmokefreeVET texting program.

The experimental WISH intervention is an HIV-specific comprehensive wellness program designed to offer integrated phone and text counseling regardless of readiness to quit.

Outcomes

Primary Outcome Measures

7-day point-prevalence abstinence (PPA)
Smoking abstinence at 6-month follow-up by self-report and biochemically confirmed via saliva cotinine for a small selected group of individuals. Cotinine levels < 10 ng/ml and a self-report of 7 day PPA will be required to be coded a nonsmoker.
Any 24-hour intentional quit attempt
The primary outcome will be presence of an intentional quit attempt [yes/no] reported between randomization and 6 month follow-up. Quit attempts will be assessed at each follow-up.

Secondary Outcome Measures

Floating prolonged abstinence
A proxy for sustained abstinence appropriate for evaluating a motivational intervention, in which the start point floats based on one's actual quit date rather than a pre-determined quit date
7-day self-report point-prevalence abstinence (PPA)
Self-report of abstinence from smoking, even a puff
30-day self-report point-prevalence abstinence (PPA)
Self-report of abstinence from smoking, even a puff
Cigarettes smoked per day
Self-report; even a puff counts as smoking
HIV-specific smoking knowledge
Items validated in a survey of Smokers Living with HIV conducted by the study team during a study titled "Smoking cessation-related information, motivation, and behavioral skills specific to HIV-infected smokers" (likert scale)
Motivation to quit smoking
1-10 likert scale
Smoking cessation related to self-efficacy
1-10 likert scale on domains (each) of quitting smoking, reducing smoking, managing cravings, and stimulus control
Nicotine withdrawal symptom management (behavioral skills)
Self-report Minnesota Smoking Withdrawal Scale, Revised
Cessation medication use and adherence (behavioral skills)
Self-report and health records (pharmacy) monitoring
Absolute CD4 count
Lab value of CD4 ascertained via EHR
VACS index 2.0
Composite score based of various lab values ascertained via EHR
Intentional quit attempt frequency and duration
Behavioral Risk Factor Surveillance System (BRFSS)

Full Information

First Posted
July 30, 2020
Last Updated
September 18, 2023
Sponsor
Seattle Institute for Biomedical and Clinical Research
Collaborators
Kaiser Permanente, University of California, Davis, Fred Hutchinson Cancer Center, US Department of Veterans Affairs
search

1. Study Identification

Unique Protocol Identification Number
NCT04505371
Brief Title
Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
Acronym
WISH
Official Title
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 4, 2021 (Actual)
Primary Completion Date
August 31, 2024 (Anticipated)
Study Completion Date
August 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Seattle Institute for Biomedical and Clinical Research
Collaborators
Kaiser Permanente, University of California, Davis, Fred Hutchinson Cancer Center, US Department of Veterans Affairs

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This project will compare the effectiveness of an HIV-specific comprehensive wellness intervention designed to have broad appeal to smokers living with HIV to the effectiveness of standard care services that include referral to the National VA Quitline and SmokefreeVET texting program. Participants in both arms will have access to pharmacotherapy available through their Veterans Affairs (VA) healthcare providers.
Detailed Description
Tobacco use remains the leading preventable cause of death and illness in our society, and smoking rates are disproportionately high among people living with HIV. NCI, nicotine dependence researchers, and HIV clinicians have all called for research to evaluate targeted and tailored smoking cessation programs for smokers living with HIV (SLWH). Research suggests SLWH are largely unaware of the HIV-specific deleterious effects of smoking and often lack motivation and confidence in their ability to quit. For these reasons, we developed the Wellness Intervention for Smokers with HIV (WISH). Similar to standard care cessation services available to Veterans, WISH is delivered remotely by mobile phone (voice and text message). The program is designed for all SLWH, regardless of their initial motivation to quit. WISH follows evidence-based, best practice guidelines for nicotine dependence treatment, but is innovative in its use of a more comprehensive wellness approach. That is, the intervention addresses both smoking and a number of other personally relevant health behaviors (such as treatment engagement, medication adherence, stress and mood management, social support, alcohol use, etc.), making it relevant and engaging to all SLWH, not just those ready to stop smoking. For those not yet ready to quit, WISH is designed to build and strengthen motivation and self-confidence for quitting, while smokers also work on other personal health goals. Once ready to quit smoking, participants receive evidence-based cognitive-behavioral counseling and encouragement to access nicotine replacement therapy (NRT) or other appropriate pharmacotherapy through usual care VA procedures. Medications will not be prescribed or dispensed by the study, allowing use of these standard services to be compared across study groups. In this two-group randomized trial, we will compare the effectiveness of WISH to standard care services offered through the National VA Quitline and the SmokefreeVET texting program (tobacco cessation services available to all Veterans). Participants in both study groups can receive phone/ text counseling and have access to pharmacotherapy through VA. Cessation services in both study groups will be provided and overseen by the non-VA sites that developed each program. Smoking-related outcomes will include 7-day point prevalence smoking abstinence and presence of any 24-hour intentional quit attempts, prolonged abstinence, and change in cigarettes per day. We will measure change in smoking-related knowledge, motivation and behavioral skills, as well as intervention reach and implementation. We will also describe comorbidities and explore intervention impact on markers of immune status and mortality risk using clinical data resources available through the Veterans Aging Cohort Study (VACS). If effective, WISH could meaningfully increase the reach of cessation services and reduce smoking among HIV+ Veterans nationwide. To support this goal, dissemination efforts are planned in Year 5 to share the WISH program with the National VA Quitline. Because VA is the largest U.S. provider of HIV care, this research has the potential for significant public health impact.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections, Smoking, Smoking Cessation
Keywords
HIV, Smoking, Smoking Cessation, Behavioral Intervention, Remote Intervention, Motivational Interviewing, Veterans

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
226 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control - Standard Care
Arm Type
No Intervention
Arm Description
The control intervention is referral to standard evidence-based cessation services available nationally to Veterans, including the National VA Quitline and SmokefreeVET texting program.
Arm Title
Intervention - Wellness Intervention for Smokers with HIV
Arm Type
Experimental
Arm Description
The experimental WISH intervention is an HIV-specific comprehensive wellness program designed to offer integrated phone and text counseling regardless of readiness to quit.
Intervention Type
Behavioral
Intervention Name(s)
Wellness Intervention for Smokers with HIV
Intervention Description
WISH is delivered remotely by mobile phone (voice and text message). WISH addresses both smoking and a number of other personally relevant health behaviors (such as treatment engagement, medication adherence, stress and mood management, social support, alcohol use, etc.), making it relevant and engaging to all, not just those ready to stop smoking. For those not yet ready to quit, WISH is designed to build and strengthen motivation and self-confidence for quitting, while smokers also work on other personal health goals. Once ready to quit smoking, participants receive evidence-based cognitive-behavioral counseling and encouragement to access nicotine replacement therapy (NRT) or other appropriate pharmacotherapy through usual care VA procedures. Medications will not be prescribed or dispensed by the study.
Primary Outcome Measure Information:
Title
7-day point-prevalence abstinence (PPA)
Description
Smoking abstinence at 6-month follow-up by self-report and biochemically confirmed via saliva cotinine for a small selected group of individuals. Cotinine levels < 10 ng/ml and a self-report of 7 day PPA will be required to be coded a nonsmoker.
Time Frame
6 months post-randomization
Title
Any 24-hour intentional quit attempt
Description
The primary outcome will be presence of an intentional quit attempt [yes/no] reported between randomization and 6 month follow-up. Quit attempts will be assessed at each follow-up.
Time Frame
3 and 6 months postrandomization
Secondary Outcome Measure Information:
Title
Floating prolonged abstinence
Description
A proxy for sustained abstinence appropriate for evaluating a motivational intervention, in which the start point floats based on one's actual quit date rather than a pre-determined quit date
Time Frame
3 and 6 months post-randomization
Title
7-day self-report point-prevalence abstinence (PPA)
Description
Self-report of abstinence from smoking, even a puff
Time Frame
3 and 6 months post-randomization
Title
30-day self-report point-prevalence abstinence (PPA)
Description
Self-report of abstinence from smoking, even a puff
Time Frame
3, 6, 12 months post-randomization
Title
Cigarettes smoked per day
Description
Self-report; even a puff counts as smoking
Time Frame
3 and 6 months post-randomization
Title
HIV-specific smoking knowledge
Description
Items validated in a survey of Smokers Living with HIV conducted by the study team during a study titled "Smoking cessation-related information, motivation, and behavioral skills specific to HIV-infected smokers" (likert scale)
Time Frame
3 and 6 months post-randomization
Title
Motivation to quit smoking
Description
1-10 likert scale
Time Frame
3 and 6 months post-randomization
Title
Smoking cessation related to self-efficacy
Description
1-10 likert scale on domains (each) of quitting smoking, reducing smoking, managing cravings, and stimulus control
Time Frame
3 and 6 months post-randomization
Title
Nicotine withdrawal symptom management (behavioral skills)
Description
Self-report Minnesota Smoking Withdrawal Scale, Revised
Time Frame
3 and 6 months post-randomization
Title
Cessation medication use and adherence (behavioral skills)
Description
Self-report and health records (pharmacy) monitoring
Time Frame
3 and 6 months post-randomization
Title
Absolute CD4 count
Description
Lab value of CD4 ascertained via EHR
Time Frame
6 and 12 months post-randomization
Title
VACS index 2.0
Description
Composite score based of various lab values ascertained via EHR
Time Frame
6 and 12 months post-randomization
Title
Intentional quit attempt frequency and duration
Description
Behavioral Risk Factor Surveillance System (BRFSS)
Time Frame
3 and 6 months post-randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: In care in the VA HIV+ serostatus Currently smoking 5+ cigarettes daily Access to cell phone with text messaging capabilities English speaking Exclusion Criteria: Psychosis, dementia or significant cognitive impairment documented in the EHR Documented or observed hearing or comprehension difficulties that would preclude participation in study telephone calls Currently receiving cessation counseling or using an FDA approved treatment to quit smoking Institutionalized/imprisoned Pregnant
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
John Kundzins, BS
Phone
(206) 268-5278
Email
John.Kundzins@VA.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Kristina Crothers, MD
Phone
(206) 277-3013
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristina Crothers, MD
Organizational Affiliation
VA Puget Sound Health Care System
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Puget Sound Health Care System Seattle Division
City
Seattle
State/Province
Washington
ZIP/Postal Code
98108
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
John Kundzins, BS
Phone
206-768-5278
Email
John.Kundzins@va.gov
First Name & Middle Initial & Last Name & Degree
Kristina A Crothers, MD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV

We'll reach out to this number within 24 hrs